MicroRNA-665 inhibits the oncogenicity of retinoblastoma by directly targeting high-mobility group box 1 and inactivating the Wnt/β-catenin pathway

Shuai Wang, Shanshan Du, Yong Lv, Fengyan Zhang, Wenzhan WangDepartment of Ophthalmology, The First Affiliated Hospital of Zhengzhou University, Zhengzhou, Henan 450052, People’s Republic of ChinaPurpose: Previous studies have revealed that microRNA-665 (miR-665) is dysregulated in a varie...

Full description

Bibliographic Details
Main Authors: Wang S, Du S, Lv Y, Zhang F, Wang W
Format: Article
Language:English
Published: Dove Medical Press 2019-04-01
Series:Cancer Management and Research
Subjects:
Online Access:https://www.dovepress.com/microrna-665-inhibits-the-oncogenicity-of-retinoblastoma-by-directly-t-peer-reviewed-article-CMAR
_version_ 1818272165578932224
author Wang S
Du S
Lv Y
Zhang F
Wang W
author_facet Wang S
Du S
Lv Y
Zhang F
Wang W
author_sort Wang S
collection DOAJ
description Shuai Wang, Shanshan Du, Yong Lv, Fengyan Zhang, Wenzhan WangDepartment of Ophthalmology, The First Affiliated Hospital of Zhengzhou University, Zhengzhou, Henan 450052, People’s Republic of ChinaPurpose: Previous studies have revealed that microRNA-665 (miR-665) is dysregulated in a variety of human cancers. However, little is known regarding its expression profiles and functions in retinoblastoma (RB). Therefore, the aims of our study were to evaluate miR-665 expression in RB and determine the precise roles of miR-665 in the progression of RB.Patients and methods: Herein, RT-qPCR was used to determine miR-665 expression levels in RB tissues and cell lines, and a series of functional experiments were performed to explore the influence of miR-665 on RB cell proliferation, colony formation, apoptosis, migration, and invasion as well as tumor growth. The molecular mechanisms underlying the tumor-suppressive action of miR-665 in RB were also explored.Results: We found that miR-665 was markedly reduced in RB tissues and cell lines and that lower miR-665 expression was strongly associated with tumor size, TNM stage, and differentiation in patients with RB. Exogenous expression of miR-665 suppressed cell proliferation, colony formation, migration, and invasion, and induced cell apoptosis in RB cells, while silencing miR-665 expression had the opposite effects. In addition, upregulation of miR-665 decreased the tumor growth of RB cells in vivo. High-mobility group box 1 (HMGB1) was identified as a direct target of miR-665 in RB cells, and decreasing the expression of HMGB1 simulated the regulatory effects of miR-665 overexpression in RB cells, while knockdown of HMGB1 expression counteracted the miR-665-mediated antitumor effects in RB cells. Moreover, miR-665 was shown to regulate the Wnt/β-catenin signaling pathway by targeting HMGB1 in vitro and in vivo.Conclusion: Taken together, our in vitro and in vivo results suggest that miR-665 acts as a tumor-suppressive miRNA in RB by directly targeting HMGB1 and inactivating the Wnt/β-catenin pathway. Hence, this miRNA is a candidate prognostic biomarker and therapeutic target in patients with RB.Keywords: microRNA-665, retinoblastoma, high-mobility group box 1, Wnt/β-catenin pathway, oncogenicity
first_indexed 2024-12-12T21:37:44Z
format Article
id doaj.art-134a030c9b91484c806a11f382e2f6d7
institution Directory Open Access Journal
issn 1179-1322
language English
last_indexed 2024-12-12T21:37:44Z
publishDate 2019-04-01
publisher Dove Medical Press
record_format Article
series Cancer Management and Research
spelling doaj.art-134a030c9b91484c806a11f382e2f6d72022-12-22T00:11:08ZengDove Medical PressCancer Management and Research1179-13222019-04-01Volume 113111312345094MicroRNA-665 inhibits the oncogenicity of retinoblastoma by directly targeting high-mobility group box 1 and inactivating the Wnt/β-catenin pathwayWang SDu SLv YZhang FWang WShuai Wang, Shanshan Du, Yong Lv, Fengyan Zhang, Wenzhan WangDepartment of Ophthalmology, The First Affiliated Hospital of Zhengzhou University, Zhengzhou, Henan 450052, People’s Republic of ChinaPurpose: Previous studies have revealed that microRNA-665 (miR-665) is dysregulated in a variety of human cancers. However, little is known regarding its expression profiles and functions in retinoblastoma (RB). Therefore, the aims of our study were to evaluate miR-665 expression in RB and determine the precise roles of miR-665 in the progression of RB.Patients and methods: Herein, RT-qPCR was used to determine miR-665 expression levels in RB tissues and cell lines, and a series of functional experiments were performed to explore the influence of miR-665 on RB cell proliferation, colony formation, apoptosis, migration, and invasion as well as tumor growth. The molecular mechanisms underlying the tumor-suppressive action of miR-665 in RB were also explored.Results: We found that miR-665 was markedly reduced in RB tissues and cell lines and that lower miR-665 expression was strongly associated with tumor size, TNM stage, and differentiation in patients with RB. Exogenous expression of miR-665 suppressed cell proliferation, colony formation, migration, and invasion, and induced cell apoptosis in RB cells, while silencing miR-665 expression had the opposite effects. In addition, upregulation of miR-665 decreased the tumor growth of RB cells in vivo. High-mobility group box 1 (HMGB1) was identified as a direct target of miR-665 in RB cells, and decreasing the expression of HMGB1 simulated the regulatory effects of miR-665 overexpression in RB cells, while knockdown of HMGB1 expression counteracted the miR-665-mediated antitumor effects in RB cells. Moreover, miR-665 was shown to regulate the Wnt/β-catenin signaling pathway by targeting HMGB1 in vitro and in vivo.Conclusion: Taken together, our in vitro and in vivo results suggest that miR-665 acts as a tumor-suppressive miRNA in RB by directly targeting HMGB1 and inactivating the Wnt/β-catenin pathway. Hence, this miRNA is a candidate prognostic biomarker and therapeutic target in patients with RB.Keywords: microRNA-665, retinoblastoma, high-mobility group box 1, Wnt/β-catenin pathway, oncogenicityhttps://www.dovepress.com/microrna-665-inhibits-the-oncogenicity-of-retinoblastoma-by-directly-t-peer-reviewed-article-CMARmicroRNA-665retinoblastomahigh-mobility group box 1Wnt/β-catenin pathwayoncogenicity
spellingShingle Wang S
Du S
Lv Y
Zhang F
Wang W
MicroRNA-665 inhibits the oncogenicity of retinoblastoma by directly targeting high-mobility group box 1 and inactivating the Wnt/β-catenin pathway
Cancer Management and Research
microRNA-665
retinoblastoma
high-mobility group box 1
Wnt/β-catenin pathway
oncogenicity
title MicroRNA-665 inhibits the oncogenicity of retinoblastoma by directly targeting high-mobility group box 1 and inactivating the Wnt/β-catenin pathway
title_full MicroRNA-665 inhibits the oncogenicity of retinoblastoma by directly targeting high-mobility group box 1 and inactivating the Wnt/β-catenin pathway
title_fullStr MicroRNA-665 inhibits the oncogenicity of retinoblastoma by directly targeting high-mobility group box 1 and inactivating the Wnt/β-catenin pathway
title_full_unstemmed MicroRNA-665 inhibits the oncogenicity of retinoblastoma by directly targeting high-mobility group box 1 and inactivating the Wnt/β-catenin pathway
title_short MicroRNA-665 inhibits the oncogenicity of retinoblastoma by directly targeting high-mobility group box 1 and inactivating the Wnt/β-catenin pathway
title_sort microrna 665 inhibits the oncogenicity of retinoblastoma by directly targeting high mobility group box 1 and inactivating the wnt beta catenin pathway
topic microRNA-665
retinoblastoma
high-mobility group box 1
Wnt/β-catenin pathway
oncogenicity
url https://www.dovepress.com/microrna-665-inhibits-the-oncogenicity-of-retinoblastoma-by-directly-t-peer-reviewed-article-CMAR
work_keys_str_mv AT wangs microrna665inhibitstheoncogenicityofretinoblastomabydirectlytargetinghighmobilitygroupbox1andinactivatingthewntbetacateninpathway
AT dus microrna665inhibitstheoncogenicityofretinoblastomabydirectlytargetinghighmobilitygroupbox1andinactivatingthewntbetacateninpathway
AT lvy microrna665inhibitstheoncogenicityofretinoblastomabydirectlytargetinghighmobilitygroupbox1andinactivatingthewntbetacateninpathway
AT zhangf microrna665inhibitstheoncogenicityofretinoblastomabydirectlytargetinghighmobilitygroupbox1andinactivatingthewntbetacateninpathway
AT wangw microrna665inhibitstheoncogenicityofretinoblastomabydirectlytargetinghighmobilitygroupbox1andinactivatingthewntbetacateninpathway